(HealthDay)—Empagliflozin does not increase the risk of bone fracture in patients with type 2 diabetes, according to a study published online June 15 in Diabetes Care.
Jul 23, 2018
0
0
(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.
Dec 26, 2017
0
6
(HealthDay)—Non-vitamin K antagonist oral anticoagulants (NOACs) have been adopted into practice and are more frequently prescribed than vitamin K antagonists (VKAs) in the Global Registry on Long-Term Oral Antithrombotic ...
Feb 15, 2017
0
0
(HealthDay)—Twenty-four weeks of empagliflozin + metformin correlates with a significantly greater reduction in hemoglobin A1c (HbA1c) compared with once-daily empagliflozin or twice-daily metformin, according to a study ...
Aug 16, 2016
0
3
(HealthDay)—The magnitude of the risk of adverse outcomes associated with metamizole use varies in different studies, according to a review published online July 15 in the Journal of Clinical Pharmacy and Therapeutics.
Jul 28, 2016
0
2
(HealthDay)—For patients with type 2 diabetes at high cardiovascular risk, empagliflozin is associated with a reduction in incident or worsening nephropathy, according to a study published online June 14 in the New England ...
Jun 15, 2016
0
0
Federal health officials have approved a cheaper version of the world's top-selling insulin from Sanofi for millions of U.S. patients with diabetes.
Dec 16, 2015
0
3
Sanofi said on Tuesday it hopes to take over the consumer health care unit of German peer Boehringer Ingelheim via an asset swap, making the French pharmaceutical giant the sector's world leader.
Dec 15, 2015
0
1
Federal health regulators have approved a drug to reverse the blood-thinning effects of the popular pill Pradaxa, which has been subject to thousands of reports of severe bleeding.
Oct 16, 2015
0
18
A less-expensive version of the world's top-selling insulin, Sanofi's Lantus, could go on sale in the U.S. late next year.
Sep 28, 2015
0
3
